>_ QFI Terminal
TerminalStocks › VTAK

Catheter Precision, Inc. (VTAK) Stock

Healthcare · Medical - Devices · US
$1.21 +40.37%
Last updated Jun 19, 2026 00:02 UTC

VTAK Key Statistics

Market Cap$1.31M
P/E (TTM)-0.21
P/S (TTM)1.60
P/B (TTM)195.16
Revenue (TTM)$819,000.00
EPS (TTM)$-5.76
Dividend Yield
ROE (TTM)-239.52%
Net Margin-2,086.69%
Gross Margin27.84%
52W High$2.25
52W Low$0.85
Analyst View
Price Target
Employees22
Volume1,702,735

About Catheter Precision, Inc.

Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

CEO: David A. Jenkins. Company website

See VTAK live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open VTAK in Terminal See plans

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corporation MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.